Sanofi India Limited (SANOFI.BO)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. N. Suresh Babu | Sales & Customer Engagement Head - Diabetes and Senior Director of Diabetes | -- | -- | -- |
Sanofi India Limited
- Sector:
- Healthcare
- Industry: Drug Manufacturers - General
- Full Time Employees:
- 1,225
Description
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, epilepsy, anti-infectives, and central nervous system, as well as allergy, pain care, digestive, and nutritional health under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targocio, Combiflam, DePura, Allegra, Baralgan, BUSCOGAST, Dulcoflex, Enterogermina, Novalgin, and Avil brands through independent distributors. It also exports its products to approximately 24 countries. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.
Corporate Governance
Upcoming Events
July 24, 2025 at 10:59 AM UTC - July 28, 2025 at 12:00 PM UTC
Sanofi India Limited Earnings Date
Recent Events
April 25, 2025 at 12:00 AM UTC
Ex-Dividend Date